Dr. Mary Morrison and Dr. Gail Herrine Provide Perspective on New Postpartum Depression Medication

Mary F. Morrison, MD, MS, FACP, Professor of Psychiatry and Behavioral Science and Vice Chair for Research, Psychiatry at the Lewis Katz School of Medicine at Temple University (LKSOM) and Gail M. Herrine, MD, FACOG, IBCLC, FABM, Associate Professor of Clinical Obstetrics, Gynecology and Reproductive Science at LKSOM and Medical Director of Post-Partum at Temple University Hospital, contributed comments to Healio Primary Care Today following the FDA’s recent approval of Zulresso (brexanolone), the first drug exclusively approved for postpartum depression.